Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	133.93	117.27	91.3	57.97	55.26
Revenue Growth (YoY)	14.21%	28.44%	57.50%	4.90%	3.61%
Cost of Revenue	49.65	49.05	35.84	25.83	22.77
Gross Profit	84.27	68.22	55.47	32.14	32.49
Selling, General & Admin	74.89	77.91	64.29	37.98	35.47
Research & Development	2.1	2.39	1.34	0.92	0.87
Total Operating Expenses	76.99	80.29	65.63	38.89	36.34
Operating Income	7.28	-12.07	-10.16	-6.76	-3.85
Interest Income	0.09	-	11.84	0.03	-
Interest Expense	-3.67	-4.16	-2.94	-1.69	-1
Other Non-Operating Income (Expense)	3.29	-0.03	0.22	-	-
Total Non-Operating Income (Expense)	-0.28	-4.19	9.12	-1.66	-1
Pretax Income	7	-16.26	-1.04	-8.42	-4.85
Provision for Income Taxes	-2.03	-0.19	1.7	-0.07	-
Net Income	4.97	-16.45	0.66	-8.49	-4.85
Net Income to Common	4.97	-16.45	0.66	-8.49	-4.85
Shares Outstanding (Basic)	140	134	119	94	85
Shares Outstanding (Diluted)	150	134	127	94	85
Shares Change (YoY)	12.25%	5.42%	34.76%	10.10%	8895.44%
EPS (Basic)	0.04	-0.12	0.01	-0.09	-0.06
EPS (Diluted)	0.03	-0.12	0.01	-0.09	-0.06
Shares Outstanding	140.04	139.05	130.18	108.87	2.9
Free Cash Flow	10.16	-16.01	-10.97	-7.11	-1.68
Free Cash Flow Per Share	0.07	-0.12	-0.09	-0.08	-0.02
Gross Margin	62.92%	58.17%	60.75%	55.44%	58.79%
Operating Margin	5.44%	-10.30%	-11.13%	-11.65%	-6.97%
Profit Margin	6.74%	-13.71%	-2.99%	-14.40%	-8.77%
FCF Margin	7.59%	-13.65%	-12.02%	-12.26%	-3.03%
EBITDA	12.51	-7.85	-6.98	-5.46	-2.52
EBITDA Margin	9.34%	-6.69%	-7.65%	-9.42%	-4.56%
EBIT	7.28	-12.07	-10.16	-6.76	-3.85
EBIT Margin	5.44%	-10.30%	-11.13%	-11.65%	-6.97%
Effective Tax Rate	-28.97%	1.15%	-163.65%	0.82%	0.00%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q